We'll explore Abby’s path to Pleio, insights into how pharma can best address emotional burdens impacting adherence, and the power of personalizing patient experiences. From peer-to-patient programs to resources like rebates and educational support, Abby will share what really makes a difference in helping patients stick with their treatments.
Plus, we'll look ahead at how pharma can elevate direct-to-consumer engagement in 2025, and how the rise of GLP-1s might shape the human-first approach to patient care.
So, grab your tea and get ready for some real talk on patient experience, empathy, and why pharma should care.